| This week's sponsor is SynteractHCR. | | | |
Today's Rundown Sanofi ditches IL-4/IL-13 antibody drug in lung-scarring disease Agios’ data on leukemia drug ivosidenib doesn’t excite investors Aisling Capital raises $280M for life sciences work, down from previous funding [Sponsored] Mitotech: a (very) different approach to treating Dry Eye Chasing Biogen, AveXis posts improved gene therapy data Boehringer, Dicerna pen $201M pact to hit NASH with RNAi PPD wins 7-year HIV research contract As Amazon entry into pharma looms, CEOs see plenty of room for change in distribution Featured Story | | | Thursday, November 2, 2017 In Sanofi’s third-quarter results posted early this morning, the French Big Pharma says it is canning a phase 2 trial in idiopathic pulmonary fibrosis, following on poor results from Roche and AstraZeneca. |
|
|
| This week's sponsor is Deloitte. | | | |
Top Stories Thursday, November 2, 2017 Shares in Agios have fallen after a preview of ASH data that will be used to support an FDA filing for refractory acute myeloid leukemia candidate ivosidenib. Thursday, November 2, 2017 New York venture firm Aisling Capital has raised a solid chunk of cash for clinical-stage biotechs as it looks to build on some of its recent successes. Monday, October 30, 2017 Approximately 16 million Americans have been told by their doctor that they have Dry Eye Disease – the itchy, uncomfortable and inconvenient condition that remains the number one reason people go see an ophthalmologist. Thursday, November 2, 2017 AveXis has posted an update on the spinal muscular atrophy patients treated with its gene therapy. The latest data show an uptick in the proportion of patients able to sit unassisted and talk, fueling AveXis’ hopes of establishing AVXS-101 as a rival to Biogen’s Spinraza. Thursday, November 2, 2017 Boehringer Ingelheim has put up $201 million (€173 million) to work with Dicerna Pharmaceuticals on RNAi treatments for NASH and other chronic liver diseases. The goal is to use Dicerna’s GalXC technology to silence previously inaccessible drug targets, thereby restoring liver function. Thursday, November 2, 2017 Major CRO player Pharmaceutical Product Development (PPD) has won a lucrative seven-year government contract in infectious disease. Thursday, November 2, 2017 Online retailing giant Amazon has yet to publicly disclose any plans to get into drug sales, but the mere speculation has pharma CEOs thinking, and speaking, about how it could entirely remake their world. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: SAS In the quest to understand how a therapeutic intervention performs in actual use – in real medical practice outside the controlled environment of clinical trials – many life sciences organizations are stymied. Download now to read more. Sponsored by: Ashfield Healthcare December 5, 2017 | 2pm EST / 11am PST: Join this webinar to discover tested and proven solutions to manage vacancies. Presented by Tyler Cowan, VP, Client Solutions, Ashfield US, you’ll learn how to maintain and build momentum in field sales despite turnover. Sponsored by: Veeva CROs are leading an industry wide shift to modernize clinical systems and clinical trial processes. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. BioBasics: Biotech for the Non-Scientist November 30-December 1, 2017 | Boston, MA Drug Development Primer November 9, 2017 | San Diego, CA Drug Development Immersion November 2-3, 2017 | Boston, MA CBI’s Commercial Data Insights 2017 November 28-29, 2017 | Philadelphia, PA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 